Thromboxane-A(2)/prostaglandin-H(2) receptors Characterization and antagonism. 1991

T A Morinelli, and P V Halushka
Departments of Pharmacology and Medicine, Division of Clinical Pharmacology, Medical University of South Carolina, Charleston, SC 29425, USA.

Thromboxane A(2) (TXA(2)) is a potent vasoconstrictor and platelet aggregator whose synthesis is increased in a variety of cardiovascular diseases. TXA(2) receptor antagonists have been used to (a) establish a pathophysiologic role for TXA(2) in a variety of cardiovascular diseases, (b) subtype platelet and vascular receptors, (c) elucidate structural characteristics of the receptor, and (d) aid in its purification. However, much still remains to be learned about the structure and function of TXA(2) receptors.

UI MeSH Term Description Entries

Related Publications

T A Morinelli, and P V Halushka
December 1996, European journal of pharmacology,
T A Morinelli, and P V Halushka
April 1972, Nature,
T A Morinelli, and P V Halushka
August 1989, Biochemical and biophysical research communications,
T A Morinelli, and P V Halushka
December 2007, British journal of pharmacology,
T A Morinelli, and P V Halushka
March 1985, British journal of pharmacology,
T A Morinelli, and P V Halushka
December 1999, European journal of pharmacology,
T A Morinelli, and P V Halushka
January 1987, European journal of pharmacology,
Copied contents to your clipboard!